Background: Genetic predisposition as a cause of inflammatory bowel disease (IBD) has been proven by both family and twin studies and genetic variants associated with the disease have been identified. The aim of our study was to determine the concordance rates for IBD in German twin pairs and to eva
Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study
✍ Scribed by Pieta Lehtinen; Merja Ashorn; Sari Iltanen; Raimo Jauhola; Pekka Jauhonen; Kaija-Leena Kolho; Anssi Auvinen
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 175 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
✦ Synopsis
Background: The present study aimed to characterize the incidence of pediatric inflammatory bowel disease (IBD) in Finland and determine its temporal trends.
Methods:
The patients' data were based on the database of the Social Insurance Institution. New cases diagnosed with IBD at the age <18 years in Finland between years 1987-2003 were included. Annual incidence rates were calculated per 100,000 pediatric populations (with 95% confidence intervals [CI]). The country is divided into 21 hospital districts and regional differences were evaluated accordingly.
Results:
The incidence of pediatric IBD increased from 5 per 100,000 in 1987 to 15 per 100,000 in 2003. The average rate of increase was 6.5% per year (95% CI 5.4%-7.5%). The trends were comparable for boys and girls, also by age group. Information on disease subtype was available from 1992 and during this 12-year period the incidence of Crohn's disease (CD) increased from 2-5 per 100,000 and that of ulcerative colitis (UC) from 4-9 per 100,000.
Conclusions:
Our results demonstrate a very high incidence rate for childhood IBD and in particular UC in Finland. Furthermore, a rapid increase took place nationwide in the incidence of both CD and UC during the past two decades.
📜 SIMILAR VOLUMES
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose
## Background: To date, there have been no population-based epidemiological studies published from australia concerning the incidence of inflammatory bowel disease (ibd). our hypothesis was that the incidence of ibd in australia is at least as high as other industrialized countries, given similar g
## Background: The primary aim of the study was to estimate the incidence of Crohn's disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel disease (IBD), in Malta in a well-defined population during a 13-year study period. Methods: Diagnostic criteria for CD and UC we
## Background: The objective was to analyze whether there is an association between country of birth in first-generation immigrants and first hospitalization for an inflammatory bowel disease, and to study whether any such association remains in second-generation immigrants. ## Methods: In this
## Background: The aim was to investigate the impact of systemic steroid treatment (SST) and immunomodulators (IM) on disease course in children with inflammatory bowel disease (IBD). ## Methods : All IBD patients in eastern Denmark <15 years of age diagnosed in the period 1998-2006 starting th